Co-stimulatory blockade therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
32
NCT07020156
A First-in-Human Phase I Trial of OX118 in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 3, 2025
Completion: Oct 29, 2025
Loading map...